Utility of hemoglobin A1c in predicting diabetes risk

被引:154
作者
Edelman, D
Olsen, MK
Dudley, TK
Harris, AC
Oddone, EZ
机构
[1] Vet Adm Med Ctr, HSR&D 152, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA
[2] Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27710 USA
关键词
diabetes; screening; hemoglobin A1c;
D O I
10.1111/j.1525-1497.2004.40178.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: There is controversy surrounding the issue of whether, and how, to screen adults for type 2 diabetes. Our objective was to measure the incidence of new diabetes among outpatients enrolled in a health care system, and to determine whether hemoglobin A1c (HbA1c) values would allow risk stratification for patients' likelihood of developing diabetes over 3 years. METHODS: We conducted a prospective cohort study with 3-year follow-up at a single large, tertiary care, Department of Veterans Affairs Medical Center (VAMC). A convenience sample of 1,253 outpatients without diabetes, age 45 to 64, with a scheduled visit at the VAMC, were screened for diabetes using an initial HbA1c measurement. All subjects with HbA1c greater than or equal to 6.0% (normal, 4.0% to 6.0%) were invited for follow-up fasting plasma glucose (FPG). We then surveyed patients annually for 3 years to ascertain interval diagnosis of diabetes by a physician. The baseline screening process was repeated 3 years after initial screening. After the baseline screening, new cases of diabetes were defined as either the self-report of a physician's diagnosis of diabetes, or by HbA1c greater than or equal to 7.0% or FPG a 7.0 mmol/L at 3-year follow-up. The incidence of diabetes was calculated as the number of new cases per person-year of follow-up. RESULTS: One thousand two hundred fifty-three patients were screened initially, and 56 (4.5%) were found to have prevalent unrecognized diabetes at baseline. The 1,197 patients without diabetes at baseline accrued 3,257 person-years of follow-up. There were 73 new cases of diabetes over 3 years of follow-up, with an annual incidence of 2.2% (95% confidence interval [CI], 1.7% to 2.7%). In a multivariable logistic regression model, baseline HbA1c and baseline body mass index (BMI) were the only significant predictors of new onset diabetes, with HbA1c having a greater effect than BMI. The annual incidence of diabetes for patients with baseline HbA2c less than or equal to 5.5 was 0.8% (Cl, 0.4% to 1.2%); for HbA1c 5.6 to 6.0, 2.5% (Cl, 1.6% to 3.5%); and for HbA1c 6.1 to 6.9, 7.8% (Cl, 5.2% to 10.4%). Obese patients with HbA1c 5.6 to 6.0 had an annual incidence of diabetes of 4.1% (Cl, 2.2% to 6.0%). CONCLUSIONS: HbA1c testing helps predict the likelihood that patients will develop diabetes in the future. Patients with normal HbA1c have a low incidence of diabetes and may not require rescreening in 3 years. However, patients with elevated HbA1c who do not have diabetes may need more careful follow-up and possibly aggressive treatment to reduce the risk of diabetes. Patients with high-normal HbA1c may require follow-up sooner than 3 years, especially if they are significantly overweight or obese. This predictive value suggests that HbA1c may be a useful test for periodic diabetes screening.
引用
收藏
页码:1175 / 1180
页数:6
相关论文
共 31 条
[1]  
American Diabetes Association, 2003, DIABETES CARE, V26, P33, DOI [10.2337/di-acare.26.2007.s33, DOI 10.2337/DI-ACARE.26.2007.S33]
[2]   Tests of glycemia for the diagnosis of type 2 diabetes mellitus [J].
Barr, RG ;
Nathan, DM ;
Meigs, JB ;
Singer, DE .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (04) :263-272
[3]   Incident type 2 diabetes mellitus in African American and white adults - The atherosclerosis risk in communities study [J].
Brancati, FL ;
Kao, WHL ;
Folsom, AR ;
Watson, RL ;
Szklo, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (17) :2253-2259
[4]   Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population - The Hoorn study [J].
de Vegt, F ;
Dekker, JM ;
Jager, A ;
Hienkens, E ;
Kostense, PJ ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (16) :2109-2113
[5]   Fasting glucose concentrations and cardiovasular disease; are the new diagnostic criteria not strict enough? [J].
Dzien, A ;
Dzien-Bischinger, C ;
Hoppichler, F ;
Lechleitner, M .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 54 (03) :213-214
[6]   Screening for diabetes in an outpatient clinic population [J].
Edelman, D ;
Edwards, LJ ;
Olsen, MK ;
Dudley, TK ;
Harris, AC ;
Blackwell, DK ;
Oddone, EZ .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (01) :23-28
[7]   Predictors of progression from impaired glucose tolerance to NIDDM - An analysis of six prospective studies [J].
Edelstein, SL ;
Knowler, WC ;
Bain, RP ;
Andres, R ;
BarrettConnor, EL ;
Dowse, GK ;
Haffner, SM ;
Pettitt, DJ ;
Sorkin, JD ;
Muller, DC ;
Collins, VR ;
Hamman, RF .
DIABETES, 1997, 46 (04) :701-710
[8]  
Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757
[9]   Screening for type 2 diabetes [J].
Engelgau, MM ;
Narayan, KMV ;
Herman, WH .
DIABETES CARE, 2000, 23 (10) :1563-1580
[10]  
GERKEN KL, 1990, ARCH PATHOL LAB MED, V114, P201